64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging

Bioconjugate Chemistry

Volumn 22, Issue 8, 2011, Pages 1459-1472

  Zhou, Yang ^a   Liu, Shuang ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASES; MOLECULAR IMAGING; PARTICLE BEAMS; POSITIVE IONS; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TUMORS;

CELL PHENOTYPE; MITOCHONDRIAL TRANSMEMBRANE POTENTIALS; MITOCHONDRIAS; PHOSPHONIUM CATIONS; THERAPEUTIC DRUGS; TUMOR IMAGING; TUMOR SELECTIVITIES; TUMOR UPTAKE; TUMOUR CELLS; TUMOUR LOCALIZATION;

MITOCHONDRIA;

1,4,7,10 TETRAAZACYCLODODECANE 1,4 DIACETIC ACID CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TETRAACETIC ACID CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TETRAACETIC ACID IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TETRAACETIC ACID TETRAPHENYLPHOSPHONIUM CONJUGATE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TETRAACETIC ACID TETRAPHENYLPHOSPHONIUM CONJUGATE CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CU 64; 4 BENZYLTRIPHENYLPHOSPHONIUM F 18; COPPER 64; INDIUM 111; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PHOSPHONIUM DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TETRAPHENYLPHOSPHONIUM C 11; TETRAPHENYLPHOSPHONIUM F 18; TETRAPHENYLPHOSPHONIUM H 3; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG; CATION; COPPER; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; TETRAPHENYLPHOSPHONIUM;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG RETENTION; DRUG STABILITY; DRUG STRUCTURE; DRUG UPTAKE; HEART MUSCLE PERFUSION; HUMAN; LIPID MEMBRANE; LIPOPHILICITY; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; PHYSICAL CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL; CHEMISTRY; METHODOLOGY; NEOPLASM; REVIEW; SCINTISCANNING;

COPPER RADIOISOTOPES; HUMANS; NEOPLASMS; ONIUM COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 80051761460     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200106p     Document Type: Article

References (96)

1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010 CA Cancer J. Clin. 60, 277-300
2. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis Annu. Rev. Physiol. 60, 619-642 (Pubitemid 28157889)
3. Modica-Napolitano, J. S. and Aprille, J. R. (2001) Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells Adv. Drug Delivery Rev. 49, 63-70 (Pubitemid 32493800)
4. Duchen, M. R. (2004) Mitochondria in health and disease: perspectives on a new mitochondrial biology Mol. Aspects Med. 25, 365-451 (Pubitemid 39070333)
5. Modica-Napolitano, J. S. and Singh, K. K. (2002) Mitochondria as targets for detection and treatment of cancer Expert Rev. Mol. Med. 4, 1-19
6. Johnson, L. V., Walsh, M. L., and Chen, L. B. (1980) Localization of mitochondria in living cells with rhodamine 123 Proc. Natl. Acad. Sci. U. S. A. 77, 990-994 (Pubitemid 10105043)
7. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepard, E. L., and Chen, L. B. (1982) Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells Proc. Natl. Acad. Sci. U. S. A. 79, 5292-5296 (Pubitemid 12002199)
8. Modica-Napolitano, J. S. and Aprille, J. R. (1987) Basis for the selective cytotoxicity of rhodamine 123 Cancer Res. 47, 4361-4365 (Pubitemid 17128145)
9. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B. (1985) Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells J. Biol. Chem. 260, 13844-13850 (Pubitemid 16233244)
10. Dairkee, S. H. and Hackett, A. J. (1991) Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue Breast Cancer Res. Treat. 18, 57-61
11. Mannella, C. A. (2006) The relevance of mitochondrial membrane topology to mitochondrial function Biochim. Biophys. Acta 1762, 140-147 (Pubitemid 43006021)
12. Gottlieb, E. and Thompson, C. B. (2003) Targeting the mitochondria to enhance tumor suppression Methods Mol. Biol. 223, 543-554
13. Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Da Ros, T., Hurd, T. R., Smith, R. A., and Murphy, M. P. (2005) Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology Biochemistry (Mosc.) 70, 222-230 (Pubitemid 40512331)
14. Jakobs, S. (2006) High resolution imaging of live mitochondria Biochim. Biophys. Acta 1763, 561-575 (Pubitemid 44015949)
15. Lichtshtein, D., Kaback, H. R., and Blume, A. J. (1979) Use of a lipophilic cation for determination of membrane potential in neuroblastoma-glioma hybrid cell suspensions Proc. Natl. Acad. Sci. U. S. A. 76, 650-654 (Pubitemid 9135650)
16. Hockings, P. D. and Rogers, P. J. (1996) The measurement of transmembrane electrical potential with lipophilic cations Biochim. Biophys. Acta 1282, 101-106 (Pubitemid 26189203)
17. Huang, S. G. (2002) Development of a high throughput screening assay for mitochondrial membrane potential in living cells J. Biomol. Screen. 7, 383-389
18. Lefevre, C., Kang, H. C., Haugland, R. P., Malekzadeh, N., Arttamangkul, S., and Haugland, R. P. (1996) Texas Red-X and rhodamine Red-X, new derivatives of sulforhodamine 101 and lissamine rhodamine B with improved labeling and fluorescence properties Bioconjugate Chem. 7, 482-489 (Pubitemid 26312139)
19. Lavis, L. D., Chao, T. Y., and Raines, R. T. (2006) Fluorogenic label for biomolecular imaging ACS Chem. Biol. 1, 252-260
20. Mao, C. and Kisaalita, W. S. (2004) Determination of resting membrane potential of individual neuroblastoma cells (IMR-32) using a potentiometric dye (TMRM) and confocal microscopy J. Fluoresc. 14, 739-743
21. Scaduto, R. C., Jr and Grotyohann, L. W. (1999) Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives Biophys. J. 76, 469-477 (Pubitemid 29202474)
22. Hama, Y., Urano, Y., Koyama, Y., Kamiya, M., Bernardo, M., Paik, R. S., Shin, I. S., Paik, C. H., Choyke, P. L., and Kobayashi, H. (2007) A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate Cancer Res. 67, 2791-2799 (Pubitemid 46548968)
23. Glunde, K., Foss, C. A., Takagi, T., Wildes, F., and Bhujwalla, Z. M. (2005) Synthesis of 6′- O -lissamine-rhodamine B-glucosamine as a novel probe for fluorescence imaging of lysosomes in breast tumors Bioconjugate Chem. 16, 843-851 (Pubitemid 41026171)
24. Longmire, M. R., Ogawa, M., Hama, Y., Kosaka, N., Regino, C. A., Choyke, P. L., and Kobayashi, H. (2008) Determination of optimal rhodamine fluorophore for in vivo optical imaging Bioconjugate Chem. 19, 1735-1742
25. Yova, D., Atlamazoglou, V., Kavantzas, N., and Loukas, S. (2000) Development of a fluorescence-based imaging system for colon cancer diagnosis using two novel rhodamine derivatives Lasers Med. Sci. 15, 140-147 (Pubitemid 30209644)
26. Saha, G. B., Go, R. T., and Maclntyre, W. J. (1992) Radiopharmaceuticals for cardiovascular imaging Int. J. Rad. Appl. Instrum. B 19, 1-20
27. Jain, D. (1999) Technetium-99m labeled myocardial perfusion imaging agents Semin. Nucl. Med. 29, 221-236 (Pubitemid 29337181)
28. Acampa, W., Di Benedetto, C., and Cuocolo, A. (2000) An overview of radiotracers in nuclear cardiology J. Nucl. Cardiol. 7, 701-707 (Pubitemid 32042457)
29. Dilsizian, V. (2000) The role of myocardial perfusion imaging in vascular endothelial dysfunction J. Nucl. Cardiol. 7, 180-184 (Pubitemid 30232686)
30. Beller, G. A. and Zaret, B. L. (2000) Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease Circulation 101, 1465-1478 (Pubitemid 30169872)
31. Parker, J. A. (2001) Cardiac nuclear medicine in monitoring patients with coronary heart disease Semin. Nucl. Med. 31, 223-237 (Pubitemid 32565552)
32. Herman, L. W., Sharma, V., Kronauge, J. F., Barbarics, E., Herman, L. A., and Piwnica-Worms, D. (1995) Novel hexakis(arenisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein J. Med. Chem. 38, 2955-2963
33. Luker, G. D., Fracasso, P. M., Dobkin, J., and Piwnica-Worms, D. (1997) Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo J. Nucl. Med. 38, 369-372 (Pubitemid 27376885)
34. 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system Nucl. Med. Biol. 31, 53-65 (Pubitemid 38115125)
35. 99mTc-labeled sestamibi and tetrofosmin Nucl. Med. Biol. 32, 573-583 (Pubitemid 40981813)
36. Schomäcker, K. and Schicha, H. (2000) Use of myocardial imaging agents for tumor diagnosis: a success story? Eur. J. Nucl. Med. 27, 1845-1863
37. 99Tc-MIBI in the evaluation of breast cancer biology Eur. J. Nucl. Med. Mol. Imaging 31 (Suppl. 1) S88-S96 (Pubitemid 38833037)
38. Sharma, V. and Piwnica-Worms, D. (1999) Metal complexes for therapy and diagnosis of drug resistance Chem. Rev. 99, 2545-2560
39. Sharma, V. (2004) Radiopharmaceuticals for assessment of multidrug resistance P-glycoprotein-mediated drug transport activity Bioconjugate Chem. 15, 1464-1474 (Pubitemid 39552038)
40. Sharma, V. and Piwnica-Worms, D. (2005) Monitoring multidrug resistance P-glycoprotein drug transport activity with single-photon emission computed tomography and positron emission tomography radiopharmaceuticals Top. Curr. Chem. 252, 155-178 (Pubitemid 44420848)
41. Vaidyanathan, G. and Zalutsky, M. R. (2004) Imaging drug resistance with radiolabeled molecules Curr. Pharm. Des. 10, 2965-2979 (Pubitemid 39214005)
42. Filippi, L., Santoni, R., Manni, C., Danieli, R., Floris, R., and Schillaci, O. (2005) Imaging primary brain tumors by single-photon emission computerized tomography (SPECT) with technetium-99m Sestamibi (MIBI) and Tetrofosmin Curr. Med. Imaging Rev. 1, 61-66
43. 123I]Iodo-penten-5-yl]triphenylphosphonium iodide: convenient preparation of a potential useful myocardial perfusion agent J. Med. Chem. 27, 978-981 (Pubitemid 14057356)
44. Srivastava, P. C., Hay, H. G., and Knapp, F. F., Jr. (1985) Effects of alkyl and aryl substitution on the myocardial specificity of radioiodinated phosphonium, arsonium, and ammonium cations J. Med. Chem. 28, 901-904 (Pubitemid 15012497)
45. 11C]methyl triphenyl phosphonium: measurements of the extraction fraction and myocardial uptake J. Nucl. Biol. Med. 38, 521-526 (Pubitemid 24344266)
46. 11C]TPMP in canine brain tumor: a PET study J. Nucl. Med. 40, 1180-1185 (Pubitemid 29315511)
47. 99mTc-MIBI J. Nucl. Med. 43, 234-238 (Pubitemid 34151048)
48. 18F]fluorobenzyl triarylphosphonium ions J. Label. Compd. Radiopharm. 47, 469-476 (Pubitemid 39062538)
49. 18F-fluorobenzyl triphenyl phosphonium in dog myocardium J. Nucl. Med. 47, 1359-1366 (Pubitemid 47544892)
50. 18F]fluorophenyl)triphenylphosphonium as a potential imaging agent for mitochondrial dysfunction J. Label. Compd. Radiopharm. 48, 131-137 (Pubitemid 40313567)
51. Cheng, Z., Winant, R. C., and Gambhir, S. S. (2005) A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry J. Nucl. Med. 46, 878-886
52. Min, J. J., Biswal, S., Deroose, C., and Gambhir, S. S. (2004) Tetraphenylphosphonium as a novel molecular probe for imaging tumors J. Nucl. Med. 45, 636-643 (Pubitemid 47618595)
53. 3H-tetraphenylphosphonium by nervous system tumor cells J. Neurosurg. 74, 116-122
54. Anderson, C. J., Green, M. A., and Fujibayashi, Y. (2003) Chemistry of copper radionuclides and radiopharmaceutical products, Handbook of Radiopharmaceuticals: Radiochemistry and Applications (Welch, M. J. and Redvanly, C., Eds.) pp 401-422, John Wiley & Sons, Ltd.
55. Smith, S. V. (2004) Molecular imaging with copper-64 J. Inorg. Biochem. 98, 1874-1901 (Pubitemid 39456427)
56. Blower, P. J., Lewis, J. S., and Zweit, J. (1996) Copper radionuclides and radiopharmaceuticals in nuclear medicine Nucl. Med. Biol. 23, 957-980 (Pubitemid 27050682)
57. Liu, S. (2004) The role of coordination chemistry in development of target-specific radiopharmaceuticals Chem. Soc. Rev. 33, 1-18
58. Reichert, D. E., Lewis, J. S., and Anderson, C. J. (1999) Metal complexes as diagnostic tools Coord. Chem. Rev. 184, 3-66
59. Anderson, C. J. and Welch, M. J. (1999) Radiometal-labeled agents (non-technetium) for diagnostic imaging Chem. Rev. 99, 2219-2234
60. Liu, S. (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides Adv. Drug Delivery Rev. 60, 1347-1370
61. 64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents J. Med. Chem. 50, 5057-5069 (Pubitemid 47585703)
62. Yang, C. T., Li, Y., and Liu, S. (2007) Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions Inorg. Chem. 46, 8988-8997
63. 64Cu-labeled triphenylphosphonium cations J. Med. Chem. 51, 2971-2984 (Pubitemid 351706025)
64. 64Cu-labeled 2-(Diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics Bioconjugate Chem. 19, 2008-2022
65. 64Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance Bioconjugate Chem. 20, 790-798
66. Deshpande, S. V., DeNardo, S. J., Meares, C. F., McCall, M. J., Adams, G. P., Moi, M. K., and DeNardo, G. L. (1988) Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice J. Nucl. Med. 29, 217-225 (Pubitemid 18056733)
67. Anderson, C. J., Pajeau, T. S., Edwards, W. B., Sherman, E. L., Rogers, B. E., and Welch, M. J. (1995) In vitro and in vivo evaluation of copper-64-octreotide conjugates J. Nucl. Med. 36, 2315-2325
68. Anderson, C. J., Jones, L. A., Bass, L. A., Sherman, E. L., McCarthy, D. W., Cutler, P. D., Lanahan, M. V., Cristel, M. E., Lewis, J. S., and Schwarz, S. W. (1998) Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats J. Nucl. Med. 39, 1944-1951 (Pubitemid 28518897)
69. 3- octreotate. A new somatostatin analog with improved target tissue uptake Nucl. Med. Biol. 26, 267-273 (Pubitemid 29179869)
70. 3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model Clin. Cancer Res. 5, 3608-3616
71. 64Cu-labeled dimeric RGD peptides Mol. Imaging Biol. 6, 350-359 (Pubitemid 39243068)
72. 64Cu-labeled tetrameric RGD peptide J. Nucl. Med. 46, 1707-1718 (Pubitemid 46211595)
73. 11), a cyclized peptide analogue of α-MSH J. Med. Chem. 48, 2985-2992 (Pubitemid 40548110)
74. 4 linkers Bioconjugate Chem. 20, 750-759
75. 2] targeting vector for positron-emission tomography imaging of gastrin- releasing peptide receptor-expressing tissues Proc. Natl. Acad. Sci. U. S. A. 104, 12462-12467 (Pubitemid 47206160)
76. 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems J. Nucl. Med. 48, 1327-1337 (Pubitemid 47242799)
77. 2+ complexes of macrocyclic polyamino carboxylates Inorg. Chem. 34, 6472-6480
78. Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., and Anderson, C. J. (2004) Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes J. Med. Chem. 47, 1465-1474 (Pubitemid 38327472)
79. Boswell, C. A., McQuade, P., Weisman, G. R., Wong, E. H., and Anderson, C. J. (2005) Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS Nucl. Med. Biol. 32, 29-38 (Pubitemid 40187379)
80. Sprague, J. E., Peng, Y., Fiamengo, A. L., Woodin, K. S., Southwick, E. A., Weisman, G. R., Wong, E. H., Golden, J. A., Rheingold, A. L., and Anderson, C. J. (2007) Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents J. Med. Chem. 50, 2527-2535 (Pubitemid 46799265)
81. Bass, L. A., Wang, M., Welch, M. J., and Anderson, C. J. (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver Bioconjugate Chem. 11, 527-532 (Pubitemid 30597722)
82. Anderson, C. J. (2001) Metabolism of radiometal-labeled proteins and peptides: what are the real radiopharmaceuticals in vivo? Cancer Biother. Radiopharm. 16, 451-455 (Pubitemid 34024433)
83. Le Jeune, N., Perek, N., Denoyer, D., and Dubois, F. (2004) Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells Cancer Biother. Radiopharm. 19, 411-421 (Pubitemid 39281333)
84. Bähr, O., Rieger, J., Duffner, F., Meyermann, R., Weller, M., and Wick, W. (2003) P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells Brain Pathol. 13, 482-494 (Pubitemid 37420693)
85. Nakatsu, S., Kondo, S., Kondo, Y., Yin, D., Peterson, J. W., Kaakaji, R., Morimura, T., Kikuchi, H., Takeuchi, J., and Barnett, G. H. (1997) Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11 Cancer Chemother. Pharmacol. 39, 417-423 (Pubitemid 27078126)
86. Ketterer, B., Neumcke, B., and Läuger, P. (1971) Transport mechanism of hydrophobic ions through lipid bilayer membranes J. Membr. Biol. 5, 225-245
87. Flewelling, R. F. and Hubbel, W. L. (1986) Hydrophobic ion interactions with membranes. Thermodynamic analysis of tetraphenylphosphonium binding to vesicles Biophy. J. 49, 531-540
88. Honig, B. H., Hubell, W. L., and Flewelling, R. F. (1986) Electrostatic interactions in membranes and proteins Annu. Rev. Biophys. Biophys. Chem. 15, 163-193
89. Grunwald, E., Baughman, G., and Kohnstam, G. (1960) The solvation of electrolytes in dioxane-water mixtures, as deduced from the effect of solvent change on the standard partial molar free energy J. Am. Chem. Soc. 82, 5801-5811
90. Kandela, I. K., Lee, W., and Indig, G. L. (2003) Effect of the lipophilic/hydrophilic character of cationic triarylmethane dyes on their selective phototoxicity toward tumor cells Biotech. Histochem. 78, 157-169 (Pubitemid 37517374)
91. Kandela, K., Bartlett, J. A., and Indig, G. L. (2002) Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells Photochem. Photobiol. Sci. 1, 309-314 (Pubitemid 37069741)
92. Horobin, R. W. (2001) Uptake, distribution, and accumulation of dyes and fluorescent probes within living cells. A structure-activity modeling approach Adv. Colour Sci. Technol. 4, 101-107
93. Fantin, V. R., Beradi, M. J., Scorrano, L., Korsmeyer, S. J., and Leder, P. (2002) A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth Cancer Cell 2, 29-42 (Pubitemid 41043986)
94. Britten, C. D., Rowinsky, E. K., Baker, S. D., Weiss, G. R., Smith, L., Stephenson, J., Rothenberg, M., Smetzer, L., Cramer, J., Collins, W., Von Hoff, D. D., and Eckhardt, S. G. (2000) A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077 Clin. Cancer Res. 6, 42-49 (Pubitemid 30064974)
95. Trapp, S. and Horobin, R. W. (2005) A predictive model for the selective accumulation of chemicals in tumor cells Eur. Biophys. J. 34, 959-966 (Pubitemid 41428192)
96. 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria. Bioconjugate Chem. 22, 700 - 708.